Taking lenient stance, NICE backs neuroblastoma drug
Body makes special case due to rarity of the disease
X
Taking lenient stance, NICE backs neuroblastoma drug
https://pharmaphorum.com/news/taking-lenient-stance-nice-backs-neuroblastoma-drug/
Body makes special case due to rarity of the disease
